|
3-2-10, Dosho-machi, Chuo-ku Osaka 541-8505, Japan Tel. +81-6-6205-5085 Fax +81-6-6205-5262 |
Type: Subsidiary
On the web:
http://www.mt-pharma.co.jp
Employees:
10,361
Japanese drug firm Mitsubishi Tanabe Pharma makes proprietary prescription pharmaceuticals in a number of therapeutic areas, including cardiovascular disease, diabetes, neuroscience, immunology, and oncology. In its home market, it sells products such as anticoagulant Anplag, anti-allergy medicine Talion, liver drug Urso, and neuroprotective agent Radicut. Its Benesis unit makes therapeutic plasma proteins such as albumin. The company markets and sells its products through in-house sales agents and distributors. Formerly Mitsubishi Pharma, the company merged with fellow Japanese drugmaker Tanabe Seiyaku and subsequently changed its name; Mitsubishi Chemical Holdings owns a majority stake in the new entity.
Key numbers for fiscal year ending March, 2008:
Sales: $4,007.5M
Officers:
President, CEO, and Director: Michihiro Tsuchiya
Managing Executive Officer, Head Sales and Marketing Division, and Director: Biopharmaceuticals & Biotherapeutics
Competitors:
Astellas
Chugai
Daiichi Sankyo
